Advanced

PARLIAMENTARY WRITTEN QUESTION
(9 December 2024)

Question Asked

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the development of a (a) safe and (b) effective Group B Streptococcus vaccine.

Asked by:
Helen Hayes (Labour)

Answer

The UK Health Security Agency’s Vaccine Development and Evaluation Centre (VDEC) has been supporting the creation of a safe and effective maternal vaccine for Group B Streptococcus (GBS).

A maternal vaccine for GBS, which protects infants from both the early and late onset of the disease, will have a positive impact on infant mortality and morbidity. It will also lead to a sharp reduction in the use of antibiotics in neonatal units worldwide. By focusing on effectiveness, through advanced immune response evaluations, these efforts are accelerating the development of a reliable GBS vaccine that can protect vulnerable populations worldwide. Further information on how VDEC is supporting a GBS vaccine to prevent newborn deaths is available at the following link:

https://www.gov.uk/government/case-studies/vdec-is-supporting-a-gbs-vaccine-to-prevent-newborn-deaths.


Answered by:
()

1 January 1970            

        

            
                            
                            
                        

                    


                                    

                    

                        

                    

                

            
                    

                                    

                

                    
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.